Patent · US Active

ErbB antagonists for pain therapy

US8333964B2 · kind B2 · utility

24Cited by
8References
46Claims
0Family size

Assignee

Inventor

Key dates

Filing dateNov 29, 2010
Grant dateDec 18, 2012
Priority date—
Expiry dateNov 29, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application describes the use of ErbB antagonist, especially ErbB2 antibodies such as rhuMAb 2C4, for treating pain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.